RankingsPricing
  1. US-listed companies
  2. Teladoc Health, Inc.
  3. Financials
  4. Total cash & short-term investments

Teladoc Health, Inc.TDOC

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndTotal cash & short-term investments (Million USD)YoY (%)
Dec 31, 20241,298+15.54%
Dec 31, 20231,124+22.38%
Dec 31, 2022918+2.47%
Dec 31, 2021896+13.92%
Dec 31, 2020787+52.12%
Dec 31, 2019517-3.00%
Dec 31, 2018533+335.86%
Dec 31, 2017122+85.85%
Dec 31, 201666-52.09%
Dec 31, 2015137

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)